IP Library Granted Patent US 10,961,185
Granted Patent B2
US 10,961,185 · App. 15/770,145 · Granted Mar 30, 2021

Stabilizer and stabilization method

Inventors: Shinya Kaji (Amagasaki, JP); Toshinari Ohashi (Amagasaki, JP); Naoyuki Yamamoto (Amagasaki, JP)
Assignee: FUJIFILM WAKO PURE CHEMICAL CHEMICAL CORPORATION
C07C309/50C07C245/08C07C245/10C07C309/35C07C309/42C07C309/43C07C309/46C07C309/47C09K11/07C09K15/28G01N21/76G01N33/50C09K11/02C09K2211/1018
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,961,185
App. No.
15/770,145
Granted
Mar 30, 2021
Kind
B2
Abstract

The invention relates to a stabilizer for L-012 or a salt thereof, a stabilization method for L-012 or a salt thereof, coexisting with the stabilizer and L-012 or a salt thereof, and the like. The stabilizer is represented by Formula [1]: wherein p pieces of M1 each independently represent a hydrogen atom or an alkali metal atom, q pieces of R1 each independently represent a hydroxy group or a sulfonic acid group, m represents 0 or 1, p represents an integer of 1 to 3, q represents an integer of 0 to 4, Y represents a nitrogen atom or a CH group (a methine group), and Z represents an aryl group having a specific structure or a pyrazolyl group having a specific structure.

Claims (18)

1. A stabilization method for 8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4(2H,3H)-dione or a salt thereof, wherein a compound selected from 4-hydroxy-5-(salicylidenamino)-2,7-naphthalenedisulfonic acid or a salt thereof, 7-hydroxy-8-(4-sulfo-1-naphthylazo)-1,3-naphthalenedisulfonic acid or a salt thereof, 2-(4-sulfophenylazo)-1,8-dihydroxy-3,6-naphthalenedisulfonic acid or a salt thereof, 3-[4-(phenylamino)phenylazo]benzenesulfonic acid or a salt thereof, and 3-hydroxy-4-[4-(4-sulfophenylazo)-2-sulfophenylazo]-2,7-naphthalenedisulfonic acid or a salt thereof is coexisted with 8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4(2H,3H)-dione or a salt thereof.

2. The stabilization method according to claim 1 , wherein the compound is 4-hydroxy-5-(salicylidenamino)-2,7-naphthalenedisulfonic acid or a salt thereof.

3. The stabilization method according to claim 1 , wherein the compound is 7-hydroxy-8-(4-sulfo-1-naphthylazo)-1,3-naphthalenedisulfonic acid or a salt thereof.

4. The stabilization method according to claim 1 , wherein the compound is 2-(4-sulfophenylazo)-1,8-dihydroxy-3,6-naphthalenedisulfonic acid or a salt thereof.

5. The stabilization method according to claim 1 , wherein the compound is 3-[4-(phenylamino)phenylazo]benzenesulfonic acid or a salt thereof.

6. The stabilization method according to claim 1 , wherein the compound is 3-hydroxy-4-[4-(4-(4-sulfophenylazo)-2-sulfophenylazo]-2,7-naphthalenedisulfonic acid or a salt thereof.

7. A composition comprising 8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4(2H,3H)-dione or a salt thereof, and a compound selected from 4-hydroxy-5-(salicylidenamino)-2,7-naphthalenedisulfonic acid or a salt thereof, 7-hydroxy-8-(4-sulfo-1-naphthylazo)-1,3-naphthalenedisulfonic acid or a salt thereof, 2-(4-sulfophenylazo)-1,8-dihydroxy-3,6-naphthalenedisulfonic acid or a salt thereof, 3-[4-(phenylamino)phenylazo]benzenesulfonic acid or a salt thereof, and 3-hydroxy-4-[4-(4-sulfophenylazo)-2-sulfophenylazo]-2,7-naphthalenedisulfonic acid or a salt thereof.

8. The composition according to claim 7 , wherein the compound is 4-hydroxy-5-(salicylidenamino)-2,7-naphthalenedisulfonic acid or a salt thereof.

9. The composition according to claim 7 , wherein the compound is 7-hydroxy-8-(4-sulfo-1-naphthylazo)-1,3-naphthalenedisulfonic acid or a salt thereof.

10. The composition according to claim 7 , wherein the compound is 2-(4-sulfophenylazo)-1,8-dihydroxy-3,6-naphthalenedisulfonic acid or a salt thereof.

11. The composition according to claim 7 , wherein the compound is 3-[4-(phenylamino)phenylazo]benzenesulfonic acid or a salt thereof.

12. The composition according to claim 7 , wherein the compound is 3-hydroxy-4-[4-(4-sulfophenylazo)-2-sulfophenylazo]-2,7-naphthalenedisulfonic acid or a salt thereof.

13. A kit for measuring a luminescence, comprising 8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,3(2H,3H)-dione or a salt thereof, and a compound selected from 4-hydroxy-5-(salicylidenamino)-2,7-naphthalenedisulfonic acid or a salt thereof, 7-hydroxy-8-(4-sulfo-1-naphthyl azo)-1,3-naphthalenedisulfonic acid or a salt thereof, 2-(4-sulfophenylazo)-1,8-dihydroxy-3,6-naphthalenedisulfonic acid or a salt thereof, 3-[4-(phenylamino)phenylazo]benzenesulfonic acid or a salt thereof, and 3-hydroxy-4-[4-(4-sulfophenylazo)-2-sulfophenylazo]-2,7-naphthalenedisulfonic acid or a salt thereof.

14. The kit for measuring a luminescence according to claim 13 , wherein the compound is 4-hydroxy-5-(salicylidenamino)-2,7-naphthalenedisulfonic acid or a salt thereof.

15. The kit for measuring a luminescence according to claim 13 , wherein the compound is 7-hydroxy-8-(4-sulfo-1-naphthylazo)-1,3-naphthalenedisulfonic acid or a salt thereof.

16. The kit for measuring a luminescence according to claim 13 , wherein the compound is 2-(4-sulfophenylazo)-1,8-dihydroxy-3,6-naphthalenedisulfonic acid or a salt thereof.

17. The kit for measuring a luminescence according to claim 13 , wherein the compound is 3-[4-(phenylamino)phenylazo]benzenesulfonic acid or a salt thereof.

18. The kit for measuring a luminescence according to claim 13 , wherein the compound is 3-hydroxy-4-[4-(4-sulfophenylazo)-2-sulfophenylazo]-2,7-naphthalenedisulfonic acid or a salt thereof.

Assignments (2)
CHANGE OF NAME Recorded Jun 13, 2018
From: WAKO PURE CHEMICAL INDUSTRIES, LTD.
To: FUJIFILM WAKO PURE CHEMICAL CORPORATION
Reel/Frame 046075/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2018
From: KAJI, SHINYA; OHASHI, TOSHINARI; YAMAMOTO, NAOYUKI
To: WAKO PURE CHEMICAL INDUSTRIES, LTD.
Reel/Frame 045605/0477 →
Priority Claims (1)
JP JP2015-207370 · Oct 21, 2015 · national
Continuity (1)
Related Publication 20180290969A1 · Oct 11, 2018